Role of the Mitochondrial Permeability Transition in Bone Metabolism and Aging
Journal of Bone and Mineral Research · 2020
DOI: 10.1002/jbmr.4787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Research, 2020. Verfasst von Rubens Sautchuk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Musculoskeletal ResearchUniversity of Rochester, Rochester, NY, USA. Hauptthemen laut MEDLINE: Mitochondrial Membrane Transport Proteins, Mitochondrial Permeability Transition Pore. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
The mitochondrial permeability transition pore (MPTP) and its positive regulator, cyclophilin D (CypD), play important pathophysiological roles in aging. In bone tissue, higher CypD expression and pore activity are found in aging; however, a causal relationship between CypD/MPTP and bone degeneration needs to be established. We previously reported that CypD expression and MPTP activity are downregulated during osteoblast (OB) differentiation and that manipulations in CypD expression affect OB differentiation and function. Using a newly developed OB-specific CypD/MPTP gain-of-function (GOF) mouse model, we here present evidence that overexpression of a constitutively active K166Q mutant of CypD (caCypD) impairs OB energy metabolism and function, and bone morphological and biomechanical parameters. Specifically, in a spatial-dependent and sex-dependent manner, OB-specific CypD GOF led to a decrease in oxidative phosphorylation (OxPhos) levels, higher oxidative stress, and general metabolic adaptations coincident with the decreased bone organic matrix content in long bones. Interestingly, accelerated bone degeneration was present in vertebral bones regardless of sex. Overall, our work confirms CypD/MPTP overactivation as an important pathophysiological mechanism leading to bone degeneration and fragility in aging. © 2023 American Society for Bone and Mineral Research (ASBMR).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Musculoskeletal ResearchUniversity of Rochester, Rochester, NY, USA.
- Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
- Department of Anesthesiology and Perioperative Medicine, University of Rochester, Rochester, NY, USA.
- Department of Pharmacology & Physiology, University of Rochester, Rochester, NY, USA.
- Department of Pediatrics, Division of Cardiology, University of Rochester, Rochester, NY, USA.
- Department of Pathology, University of Rochester, Rochester, NY, USA.
ORCID-Profile: Rubens Sautchuk, Paul S Brookes, Hani Awad, Roman A Eliseev
Förderung
- NIAMS NIH HHS
- NIA NIH HHS
- NIH HHS
- NHLBI NIH HHS
- NIDCR NIH HHS
- National Institutes of Health
Zitieren
APA
Sautchuk, R., Yu, C., McArthur, M., Massie, C., Brookes, P. S., Porter, G. A., Awad, H., & Eliseev, R. A. (2020). Role of the Mitochondrial Permeability Transition in Bone Metabolism and Aging. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.4787
Vancouver
Sautchuk R, Yu C, McArthur M, Massie C, Brookes PS, Porter GA, et al. Role of the Mitochondrial Permeability Transition in Bone Metabolism and Aging. Journal of Bone and Mineral Research. 2020. doi:10.1002/jbmr.4787
BibTeX
@article{Sautchuk2020,
author = {Sautchuk, Rubens and Yu, Chen and McArthur, Matthew and Massie, Christine and Brookes, Paul S and Porter, George A and Awad, Hani and Eliseev, Roman A},
title = {Role of the Mitochondrial Permeability Transition in Bone Metabolism and Aging},
journal = {Journal of Bone and Mineral Research},
year = {2020},
doi = {10.1002/jbmr.4787}
}
EUVIMED